Breaking News, Trials & Filings

APR, Labtec File ODF for EU Approval

Applied Pharma Research (APR) and its partner Labtec, a drug delivery developer, have submitted Zolmitriptan Oral Dispersible Film (ODF) for approval in Europe.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Applied Pharma Research (APR) and its partner Labtec, a drug delivery developer, have submitted Zolmitriptan Oral Dispersible Film (ODF) for approval in Europe. The oral dispersible film strip formulation containing the anti-migraine drug Zolmitriptan, is the second prescription product to use the RapidFilm technology and is co-developed in collaboration with Monosol Rx. The product will be manufactured for Europe at Labtec’s production site in Hamburg, Germany. Ondansetron ODF, the first ora...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters